Literature DB >> 36572

Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.

R Horowski.   

Abstract

The semisynthetic ergot derivative lisuride induced dose- and time-dependent hypothermia in rats placed in a cold environment (+4 degrees C). As regards dosage, lisuride was more than 100 times more effective in this test model than bromocriptine. The effect of both drugs could be reduced by pretreatment with the dopamine antagonist haloperidol, which indicated a dopaminergic action of both drugs. In contrast, the hypothermic effect of lisuride could not be impaired by pretreatment with sulpiride, whilst the effects of bromocriptine were clearly antagonized by this drug. This results could be explained by a different affinity of these drugs to the same receptors, or, more likely, by a different mechanism of action by which lisuride and bromocriptine activate dopaminergic systems.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36572     DOI: 10.1007/bf00498984

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

1.  Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data.

Authors:  A R Cools; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1976-02-02

2.  Influence of apomorphine hydrochloride, dibutyryl-apomorphine and Lysenyl on plasma prolactin concentrations in the rat.

Authors:  R Horowski; F Neumann; K J Gräf
Journal:  J Pharm Pharmacol       Date:  1975-07       Impact factor: 3.765

3.  Effects of bromocriptine on central dopaminergic receptors.

Authors:  M Trabucchi; P F Spano; G C Tonon; L Frattola
Journal:  Life Sci       Date:  1976-07-15       Impact factor: 5.037

4.  The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists.

Authors:  E K Silbergeld; H Adler; S Kennedy; D B Calne
Journal:  J Pharm Pharmacol       Date:  1977-10       Impact factor: 3.765

5.  Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

Authors:  A M Johnson; D M Loew; J M Vigouret
Journal:  Br J Pharmacol       Date:  1976-01       Impact factor: 8.739

6.  Release of brain dopamine as the probable mechanism for the hypothermic effect of D-amphetamine.

Authors:  S Yehuda; R J Wurtman
Journal:  Nature       Date:  1972-12-22       Impact factor: 49.962

7.  Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Authors:  K Fuxe; B B Fredholm; L F Agnati; S O Ogren; B J Everitt; G Jonsson; J A Gustafsson
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

8.  Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

Authors:  H Corrodi; K Fuxe; T Hökfelt; P Lidbrink; U Ungerstedt
Journal:  J Pharm Pharmacol       Date:  1973-05       Impact factor: 3.765

9.  Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.

Authors:  K J Gräf; F Neumann; R Horowski
Journal:  Endocrinology       Date:  1976-03       Impact factor: 4.736

10.  Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.

Authors:  R Horowski; H J Gräf
Journal:  Neuroendocrinology       Date:  1976       Impact factor: 4.914

View more
  2 in total

1.  Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.

Authors:  G Verde; P G Chiodini; A Liuzzi; R Cozzi; F Favales; L Botalla; B Spelta; D Dalla Bonzana; E Rainer; R Horowski
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

2.  Effects of lisuride on body temperature of rats and rabbits: relation to microsomal biotransformation and dopaminergic receptor stimulation.

Authors:  M O Carruba; S Ricciardi; J Negreanu; M Calogero; P Mantegazza
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.